Nearly 12 Million Patients Fall Victim to Quest Diagnostics Data Breach
Nearly 12 million people had their financial, medical and personal information exposed due to a Quest Diagnostics data breach.
About BioSpace
This author has not written his bio yet.
But we are proud to say that BioSpace contributed 3498 entries already.
Entries by BioSpace
Weekend Highlights from 2019 ASCO Annual Meeting
There was a flurry of activity during the first few days of the American Society of Clinical Oncology, with multiple presentations made showing the benefits of various oncology treatments.
Johns Hopkins Launches Liquid Biopsy Company with $110 Million Series A
Thrive Earlier Detection Corp., a liquid biopsy company, raised $110 million in Series A funding.
Merrimack to Lay Off Remaining Execs and Staff, Sell Assets
Merrimack Pharmaceuticals will lay off the Cambridge, Mass.-based company’s entire staff, including the leadership team.
Research Roundup: Mutations Linked to Autism, Protein Coats and Alzheimer’s, and More
Here is a look at some great scientific research stories recently reported.
Adaptive Biotech Plans $230 Million IPO to Advance Immune Sequencing Technologiesimmune s
Seattle-based Adaptive Biotechnologies announced plans for an initial public offering to raise up to $230 million.
ASLAN Pharma Takes on Full License of Atopic Dermatitis Drug in $775 Million-Plus Deal
Singapore-based ASLAN Pharmaceuticals amended the company’s global license agreement with CSL Limited to gain full rights to the fully human monoclonal antibody ASLAN004 being developed for atopic dermatitis and other inflammatory diseases.
Report Shows U.S. Drug Spending Expected to Increase in 2019 and in Years to Come
Despite saber-rattling, Congressional hearings, public shaming, rules regarding pricing transparency and more, the cost of spending on prescription drugs in the United States has actually increased and will likely do so for the next several years.
Novartis’ Double-Combo Therapy for Asthma Successful in Phase III Trial
Novartis’ QMF149 met primary and key secondary endpoints in the Phase III QUARTZ clinical trial for asthma.
IQVIA Global Oncology Trends: An Interview with Murray Aitken
The IQVIA Institute for Human Data Science is releasing the 2019 “Global Oncology Trends” report simultaneously with the American Society of Clinical Oncology (ASCO) Meeting.